AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06056050 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: 23-Valent Pneumococcal Polysaccharide Vaccine（PPV23）
Description: 1 dose of PPV23 vaccine (0.5ml) on Day 0
Study NCT06056050 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Diphtheria and Tetanus Combined Vaccine, Adsorbed (DT)
Description: 1 dose of DT vaccine (0.5ml) on Day 0
Study NCT05892913 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Slow dose preemptive Atropine
Description: it will planned to administer 0.4 mg/4mL diluted atropine in 20 seconds(10mcg/kg), as a slow bolus as bradycardia would expected (10% reduction in peak heart rate after spinal anesthesia)
Study NCT05892913 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ephedrine
Description: For sympathetic blockade (SBP\<90) developed in patients in the ephedrine group, a bolus dose of 5 mg/mL ephedrine was used and repeated if necessary.
Study NCT04327596 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: RF ablation of AF using CARTO 3 and a Thermocool ST SF ablation catheter
Description: Ablation of AF is standard of care in the management of patients with paroxysmal or persistent AF. The most common triggers initiating AF arise from pulmonary veins (PV) and successful electrical isolation of PV's can significantly reduce the burden of AF. Therefore, the main objective in patients undergoing ablation of AF is to achieve PV isolation.
Study NCT04831775 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Memory, Attention, and Problem Solving Skills for Diabetes
Description: The intervention is composed of 4 small-group webinar classes and home-based individual online cognitive skills practice and will be held over 8 weeks. The classes will be taught by a GRA. Classes 1 \& 2 will focus on common cognitive problems in T2DM and strategies to improve cognitive skills. Classes 3 \& 4 focus on lifestyle changes to support cognitive functioning and DM-SM skills. Each online class will follow the same format: (1) introduction/revisiting content from the previous class; (2) review of progress on computer exercises; (3) practicing cognitive strategies in class; and (4) a weekly topic. The GRA will also prescribe exercises for the following weeks.
Study NCT04831775 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Brain Games
Description: The computer-training component uses a model for cognitive training that adapts to the user through an integrated hierarchical structure. The BrainHQ website houses the interactive program that runs on standard web browsers. Participants will only need a computer, smart phone, or tablet with Internet access to securely log onto the website. Each participant will be registered by the project staff using anonymous ID numbers that will allow unlimited access during the study. The website stores each session completed, and participants can start subsequent sessions wherever they stopped the last time logged on.
Study NCT06030687 — intervention group
Intervention type: OTHER
Intervention: Ad libitum data collection
Description: Food purchase, prep, eat and toss data
Study NCT06395311 — intervention group
Intervention type: OTHER
Intervention: COPD psychological well-being assessment
Description: Patients will complete the following questionnaires: Hospital Anxiety and Depression Scale (HADS), COPD Assessment Test (CAT), State Shame and Guilt Scale (SSGS), Pulmonary Rehabilitation Adapted Index of Self-Efficacy (PRAISE), Brief Fear of Negative Evaluation Scale (BFNE), Self-Compassion Scale Short Form (SCS-SF). Dyspnea will be evaluated with the mMRC scale, and functional capacity will be assessed with the six-minute walking test (6MWT).
Study NCT06427824 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Geriatric Service/ Discharge Planning
Description: A geriatric team will meet with participants after surgery to help them reinforce the strategies they learned in the education video sessions. As part of a geriatric service, this team will also help participants plan/coordinate their discharge from the hospital after surgery.
Study NCT06427824 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: These questionnaires will ask about the participants' mobility, frailty, quality of life and additional health/risk factors before and after surgery.
Study NCT05391529 — intervention group
Intervention type: BEHAVIORAL
Intervention: Interview
Description: Semi structured patient interview via telephone
Study NCT04913090 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XZP-5610 Tablet （for Part C1）
Description: Tablet(s) administered fasted orally once daily for 1 Day
Study NCT04913090 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XZP-5610 Tablet for Part C2
Description: Tablet(s) administered after a high-fat meal orally once daily for 1 Day
Study NCT06053580 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valsartan 40 mg
Description: Valsartan 40mg twice daily for 24 weeks.
Study NCT06053580 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo twice daily for 24 weeks.
Study NCT04805528 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Acupuncture-Like Transcutaneous Electrical Stimulation (ALTENS)
Description: Twice weekly ALTENS therapy for 12 weeks
Study NCT05405933 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Propioceptive Neuromuscular Facilitation
Description: Propioceptive Neuromuscular Facilitation With Conventional Therapy for Balance and Gait
Study NCT05405933 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Balance Exercise
Description: Balance Exercise Along With Conventional Therapy for Balance and Gait
Study NCT05233787 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Tailored use of defunctioning stoma after TME
Description: Tailored use of defunctioning stoma after TME based on a 2-step process:~i) to perform or not a defunctioning stoma according to the personalized risk of anastomotic leakage (defunctioning stoma only if Anastomotic Failure Observed Risk Score=\[2-6\]), ii) to perform an early stoma closure at day 8-12, according to clinical (fever), biological (CRP level days 2 and 4 postoperatively) and radiological postoperative assessment (CT-scan with colonic contrast retrograde enema day 7-8 postoperatively)
Study NCT05233787 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Systematic use of defunctioning stoma
Description: Systematic use of defunctioning stoma for 2-3 months after TME, according to French national and international guidelines
Study NCT04920058 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitor
Description: Continuous glucose monitor - a device that monitors blood glucose levels in a continuous closed-loop manner. This can also refer to the process of continuous glucose monitoring
Study NCT04920058 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: <Active Comparator?>
Description: \<describe, Comprehensive Wellness Program incorporating a low carbohydrate diet (\<50g/day) and associated education >
Study NCT04920058 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: <Active Comparator?>
Description: \<describe, Comprehensive Wellness Program incorporating a low carbohydrate diet (\<50g/day) and associated education >
Study NCT05171660 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab Injection
Description: Sintilimab Injection: 200 mg, i.v., D1, Q3W, 8 courses
Study NCT05171660 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Control Test
Description: XELOX + Bevacizumab
Study NCT05171660 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Control Test
Description: XELOX + Bevacizumab
Study NCT04839146 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ABNCoV2 Vaccine
Description: SARS-CoV-2 vaccine
Study NCT03417206 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remifentanil
Description: a rate of infusion will be increased by 50% every 5 minutes until PRD decreases below 5%
Study NCT03417206 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: pupillary dilatation reflex
Description: PRD value will me measured before the start of FESS after 5 minutes of remifentanyl infusion, when PRD sensitivity > 5% , infusion of remifentanyl will be increased by 50% until PRD sensitivity \<5% and FESS will be started ; intraoperatively infusion of remifentanyl will be increased by 50% until PRD sensitivity \<5%
Study NCT01733576 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: HD-tDCS
Study NCT01733576 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: HD-tDCS
Study NCT05722249 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness and Sleep Hygiene
Description: Participants will experience demonstrations and explanations regarding sleep hygiene, mindfulness alerts for at work and mindfulness rest for at home.
Study NCT05722249 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Phyical activity and Sleep Hygiene
Description: All enrolled participants in the inpatient units randomly assigned to Arm B during Study Period 1 will receive written guidelines about physical activity during the nightshift (please see Appendix V). These guidelines will instruct them to achieve the goal of up to 15 minutes of physical activity between midnight and 0500 each nightshift during the 8-week study period. Each enrolled participant will view a video with voice over of the study team physical therapist demonstrating the methods
Study NCT05772286 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 763SIP8/MPLA-5 vaccine
Description: 763SIP8/MPLA-5 vaccine at day 0, week 8, week 24 and week 48.
Study NCT05887466 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Allogenic embryonic stem cell-derived A9 dopamine progenitor cell (A9-DPC) Low Dose
Description: Biological/Vaccine: Allogenic embryonic stem cell-derived A9 dopamine progenitor cell (A9-DPC)_Low Dose~1. IP Name : Allogenic embryonic stem cell-derived A9 dopamine progenitor cell (A9-DPC)~2. Main ingredients and quantities: A9-DPC -Low Dose :~   7.0X10\^6 cells (Use 3.15X10\^6 cells of this)~3. Formulation: milky white cell suspension~4. Storage method: Refrigerated storage (5±3#)~5. Expiration date: within 36 hours of manufacture~6. Frequency: single dosing~7. Method: The subject pierces a burr hole in the skull on the day of surgery. Then the cells are injected at a predetermined stem cell administration point of the putamen in the brain of the subject. One side is administered in three tracks per putamen (6 tracks total brain). Do the same for the other side.
Study NCT05887466 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Allogenic embryonic stem cell-derived A9 dopamine progenitor cell (A9-DPC) High Dose
Description: Biological/Vaccine: Allogenic embryonic stem cell-derived A9 dopamine progenitor cell (A9-DPC)_High Dose~1. IP Name : Allogenic embryonic stem cell-derived A9 dopamine progenitor cell (A9-DPC)~2. Main ingredients and quantities: A9-DPC -High Dose :~   1.4X10\^7 cells (Use 6.30X10\^6 cells of this)~3. Formulation: milky white cell suspension~4. Storage method: Refrigerated storage (5±3#)~5. Expiration date: within 36 hours of manufacture~6. Frequency: single dosing~7. Method: The subject pierces a burr hole in the skull on the day of surgery. Then the cells are injected at a predetermined stem cell administration point of the putamen in the brain of the subject. One side is administered in three tracks per putamen (6 tracks total brain). Do the same for the other side.
Study NCT06199752 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: probiotic agent 25 Billion CFU (Nowfoods, USA) , ). Inulin capsules 1000mg Herbamama USA
Description: probiotic agent 25 Billion CFU (Nowfoods, USA), composed of ten strains of bacteria (Lactobacillus acidophilus, Bifidobacterium lactis, Lactobacillus plantaLactobacillus paracasei, Bifidobacterium breve, Streotococcus thermophiles, Lactobacillus salivarius, and Bifidobacterium longum),
Study NCT06199752 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: probiotic agent 25 Billion CFU (Nowfoods, USA) , ). Inulin capsules 1000mg Herbamama USA
Description: probiotic agent 25 Billion CFU (Nowfoods, USA), composed of ten strains of bacteria (Lactobacillus acidophilus, Bifidobacterium lactis, Lactobacillus plantaLactobacillus paracasei, Bifidobacterium breve, Streotococcus thermophiles, Lactobacillus salivarius, and Bifidobacterium longum),
Study NCT06549608 — intervention group
Intervention type: DRUG
Intervention: Mavacamten
Description: As per product label
Study NCT06099002 — intervention group
Intervention type: OTHER
Intervention: Changed Medical research Council,Mini Mental Test, Quadriceps Femoris muscle strength measurement,2 min walking test, fall effectiveness scale,Fall risk self-assessment scale
Description: All individuals were given a respiratory function test to evaluate respiratory functions before and after training Modified Medical research Council to evaluate dyspnea, Mini Mental Test to evaluate cognitive status~, Berg Balance Test to evaluate balance, 2-minute walk test to evaluate walking speed. A hand dynamometer will be used to measure QuadricepsFemoris muscle strength, Fall efficiency scale Fall risk self-assessment scale will be used to evaluate falls.
Study NCT04775979 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: diphenylcyclopropenone (DPCP)
Description: Depigmenting agent
Study NCT05419986 — intervention group
Intervention type: GENETIC
Group type: OTHER
Intervention: Blood collection
Description: Molecular monitoring by measure of DNA methylation levels in blood samples collected by fingerstick blood drops, as opposed to veinous phlebotomy
Study NCT05149599 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saccharomyces cerevisiae
Description: Saccharomyces cerevisiae, which is a pro-biotic, was given in capsule form, 500mg twice daily for 1 month
Study NCT06558084 — intervention group
Intervention type: DRUG
Intervention: CDK4/6 Inhibitor
Description: CDK4/6 inhibitor in first and second lines
Study NCT04506086 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Blinatumomab
Description: Participants will receive blinatumomab continuous IV infusion for a maximum of 4 cycles. Each cycle is 6 weeks in duration consisting of 4 weeks of treatment and 2 weeks of rest.
Study NCT04506086 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Current Wearable Heatlth Monitoring System (CWHMS)
Description: The study will use the CWHMS device to monitor participants' vital signs while they are at home.
Study NCT05933447 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rodatristat Ethyl
Description: Oral, Tablet, 300 mg QD, 300 mg BID, 600 mg BID, 900 mg BID, 900 mg QD
Study NCT05933447 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Moxifloxacin
Description: Oral, Tablet, 400 mg QD
Study NCT05933447 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo for Rodatristat
Description: Oral, Tablet, O mg QD, 0 mg BID
Study NCT05933447 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo for Moxifloxacin
Description: Oral, Tablet, 0 mg QD
Study NCT05312372 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combination (S095033 + paclitaxel)
Description: Phase 1- dose escalation S095033 ; paclitaxel started at 80 mg/m²,(IV)~Phase 2 - S095033 at RP2D; paclitaxel started at 80 mg/m²,(IV)
Study NCT05271461 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Low level laser Therapy
Description: Pin pointed application of low level laser on 15 acupuncture points each point 1 min time of application 15 min.
Study NCT05271461 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Circulatory exercises
Description: Active assisted or against mild resistance. Supine with leg up position 18degrees measured by the bed water balance in side rails.~If patient is not comfortable according to the modified Borg scale or contra indicated for the position then assume the supine position.~The subject will have A 3 min rest period to acclimatize themselves to each position.~The ankle pumping exercises consisted of simple repetitions of dorsiflexion 1 sec and planter- flexion for 1 sec with three different exercise intervals:~* repeated dorsiflexion and planter-flexion with no rest (no rest exercise).~* repeated dorsiflexion and planter-flexion with a 2 sec rest period (2 sec rest exercise).~* repeated dorsiflexion and planter-flexion with 4sec rest period (4sec rest exercise).~Subjects will have practiced ankle pumps before the exercise to get familiar and be educated about the procedure.
Study NCT05271461 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Circulatory exercises
Description: Active assisted or against mild resistance. Supine with leg up position 18degrees measured by the bed water balance in side rails.~If patient is not comfortable according to the modified Borg scale or contra indicated for the position then assume the supine position.~The subject will have A 3 min rest period to acclimatize themselves to each position.~The ankle pumping exercises consisted of simple repetitions of dorsiflexion 1 sec and planter- flexion for 1 sec with three different exercise intervals:~* repeated dorsiflexion and planter-flexion with no rest (no rest exercise).~* repeated dorsiflexion and planter-flexion with a 2 sec rest period (2 sec rest exercise).~* repeated dorsiflexion and planter-flexion with 4sec rest period (4sec rest exercise).~Subjects will have practiced ankle pumps before the exercise to get familiar and be educated about the procedure.
Study NCT06183528 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pericapsular Nerve Group (PENG) Block
Description: With ultrasonography-guided PENG block, the femoral, obturator and accessory obturator nerve branches that provide sensory innervation of the anterior surface of the hip joint capsule are blocked .
Study NCT06183528 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Pericapsular Nerve Group (PENG) Block
Description: With ultrasonography-guided PENG block, the femoral, obturator and accessory obturator nerve branches that provide sensory innervation of the anterior surface of the hip joint capsule are blocked .
Study NCT06038175 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Video Head Impulse Testing
Description: During vHIT testing a commercially available mono-ocular video oculography system will be donned on the patient. (Interacoustics EyeSeeCam vHIT 3rd Generation Tests: VOR of lateral, RALP, \& LARP canals. SW: 3rd generation VE525 software. HW: laptop PC, lightweight monocular video goggles). Subjects will be instructed to maintain fixation at a target from 1 m distance. A study team member will deliver at least 5 head impulses per side (10-20° angle, duration 150-200 ms, peak velocity of >150°/s) in the horizontal and vertical planes with unpredictable timing and direction. A neurotologist will then evaluate the VOR gain or the ratio of eye velocity over-head velocity. The presence of refixation (catch-up) saccades, either overt or covert, will be evaluated by the study team. In line with previous literature, the vHIT testing will be considered to be abnormal if VOR gain is \<0.8 in the presence of refixation saccades .
Study NCT02124187 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ecig 24 mg nicotine
Description: eCig 24 mg nicotine for 12 weeks
Study NCT02124187 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Ecig 0 mg nicotine
Description: eCig 0 mg nicotine for 12 weeks
Study NCT06038175 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care neurologic evaluation
Description: A standard neurologic evaluation will be performed including a National Institute of Health Stroke Scale and imaging if symptoms and NIHSS warrant.
Study NCT06038175 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard of care neurologic evaluation
Description: A standard neurologic evaluation will be performed including a National Institute of Health Stroke Scale and imaging if symptoms and NIHSS warrant.
Study NCT02124187 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Nicotine free inhalator
Description: eCig 24 mg nicotine for 12 weeks
Study NCT03223220 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine
Description: IV infusion
Study NCT03223220 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Normal Saline
Description: IV infusion
Study NCT03223220 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Midazolam injection
Description: Injection
Study NCT03223220 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam injection
Description: Injection
Study NCT06516796 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: Patients were retrospectively screened.
Study NCT06650787 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ultrasound was used to locate the end of the gastric tube
Description: 1. Inform the family of the purpose and method of using bedside ultrasound to guide the placement of the gastric tube, and determine the position of the end of the tube.~2. The ultrasound machine was connected to the power supply and placed on the right side of the patient.~3. Select the appropriate type of gastric tube and measure the length of the indwelling gastric tube by nursing staff before inserting the tube.~4. Nurses who had been trained in ultrasound performed ultrasound judgment on the neck and abdomen of the children. Sonographers, intensive care physicians and nursing staff jointly judged the ultrasound images.~5. Conventional judgment method was used to determine the position of gastric tube~6. Bedside chest radiography, with results obtained by a radiologist.~7. Keep your child safe at all times.